Merck & Co Inc
PAR:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Merck & Co Inc
Revenue
Merck & Co Inc
Revenue Peer Comparison
Merck & Co Inc
Glance View
Merck & Co. is a global drug company that makes prescription medicines, vaccines, and animal health products. Its best-known business is developing and selling branded drugs for cancer, infectious disease, diabetes, and other serious conditions. It also sells vaccines and medicines used by veterinarians and livestock producers. The company makes money by selling these products to hospitals, pharmacies, doctors’ offices, governments, and animal health distributors. In human health, a large part of the business depends on patented medicines that are approved by regulators and sold through the healthcare system. In animal health, it earns revenue from products that help prevent disease and treat animals on farms and in companion-animal care. Merck stands out because it is not a generic drug maker or a healthcare insurer. It is a research-driven company that spends years developing medicines, getting them approved, and protecting them with patents. That means its business depends on scientific success, regulatory approval, and the ability to keep key drugs and vaccines on the market for many years.
See Also
What is Merck & Co Inc's Revenue?
Revenue
65.8B
USD
Based on the financial report for Mar 31, 2026, Merck & Co Inc's Revenue amounts to 65.8B USD.
What is Merck & Co Inc's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Merck & Co Inc have been 4% over the past three years , 9% over the past five years , and 5% over the past ten years .